open access

Vol 14, No 2 (2018)
Review paper
Published online: 2018-04-26
Get Citation

Nutritional therapy during the treatment of head and neck cancer

Aleksandra Kapała
DOI: 10.5603/OCP.2018.0012
·
Oncol Clin Pract 2018;14(2):79-85.

open access

Vol 14, No 2 (2018)
REVIEW ARTICLES
Published online: 2018-04-26

Abstract

Multimodality treatments for patients with squamous cell head and neck cancer often produce significant mucositis and dysphagia, resulting in severe weight loss that requires nutritional support. Continuously progressing malnutrition is associated with shorter time to the development of complications, with shorter overall survival (OS), worse response to oncological treatment, deteriorating quality of life, and poorer performance status; moreover, cachexia strongly affects treatment tolerance. This article provides an overview of the methods of nutritional support for patients undergoing treatments for head and neck cancer: surgery, radiochemotherapy, and palliative care. Nowadays, nutritional therapy is a mandatory part of head and neck cancer management.

Abstract

Multimodality treatments for patients with squamous cell head and neck cancer often produce significant mucositis and dysphagia, resulting in severe weight loss that requires nutritional support. Continuously progressing malnutrition is associated with shorter time to the development of complications, with shorter overall survival (OS), worse response to oncological treatment, deteriorating quality of life, and poorer performance status; moreover, cachexia strongly affects treatment tolerance. This article provides an overview of the methods of nutritional support for patients undergoing treatments for head and neck cancer: surgery, radiochemotherapy, and palliative care. Nowadays, nutritional therapy is a mandatory part of head and neck cancer management.

Get Citation

Keywords

head and neck cancer, radiochemotherapy, nutritional support, malnutrition, cachexia

About this article
Title

Nutritional therapy during the treatment of head and neck cancer

Journal

Oncology in Clinical Practice

Issue

Vol 14, No 2 (2018)

Article type

Review paper

Pages

79-85

Published online

2018-04-26

DOI

10.5603/OCP.2018.0012

Bibliographic record

Oncol Clin Pract 2018;14(2):79-85.

Keywords

head and neck cancer
radiochemotherapy
nutritional support
malnutrition
cachexia

Authors

Aleksandra Kapała

References (39)
  1. Ravasco P, Monteiro-Grillo I, Marques Vidal P, et al. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005; 27(8): 659–668.
  2. Andreyev H, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? European Journal of Cancer. 1998; 34(4): 503–509.
  3. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69(4): 491–497.
  4. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004; 90(10): 1905–1911.
  5. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, et al. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg. 2008; 12(7): 1193–1201.
  6. Wheelwright S, Darlington AS, Hopkinson JB, et al. A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer. 2013; 21(9): 2625–2636.
  7. Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer. 2010; 10: 50.
  8. Aapro M, Arends J, Bozzetti F, et al. ESMO (European School of Medical Oncology). Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol. 2014; 25(8): 1492–1499.
  9. Baldwin C, Spiro A, Ahern R, et al. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012; 104(5): 371–385.
  10. Schueren Mvd, Leeuwen Pv, Sauerwein H, et al. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head & Neck. 1997; 19(5): 419–425, doi: 10.1002/(sici)1097-0347(199708)19:5<419::aid-hed9>3.0.co;2-2.
  11. Schueren Mv, Leeuwen Pv, Sauerwein H, et al. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head & Neck. 1997; 19(5): 419–425, doi: 10.1002/(sici)1097-0347(199708)19:5<419::aid-hed9>3.3.co;2-5.
  12. Kawakita D, Lee YCA, Turati F, et al. Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium. Cancer Causes Control. 2012; 23(1): 69–88.
  13. Didkowska, J., U. Wojciechowska, and W. Zatoński. Krajowy Rejestr Nowotworów. Nowotwory złośliwe w Polsce w. 2011: 14–15.
  14. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. 2017; 36(1): 11–48.
  15. Weimann A, Braga M, Harsanyi L, et al. DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr. 2006; 25(2): 224–244.
  16. Spencer L, Mann C, Metcalfe M, et al. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer. 2009; 45(12): 2077–2086.
  17. Vidal-Casariego A, Calleja-Fernández A, Villar-Taibo R, et al. Efficacy of arginine-enriched enteral formulas in the reduction of surgical complications in head and neck cancer: a systematic review and meta-analysis. Clin Nutr. 2014; 33(6): 951–957.
  18. Rowan NR, Johnson JT, Fratangelo CE, et al. Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients. Oral Oncol. 2016; 54: 42–46.
  19. Snyderman CH, Kachman K, Molseed L, et al. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope. 1999; 109(6): 915–921.
  20. Riso S, Aluffi P, Brugnani M, et al. Postoperative enteral immunonutrition in head and neck cancer patients. Clin Nutr. 2000; 19(6): 407–412.
  21. de Luis DA, Izaola O, Cuellar L, et al. Effect of c-reactive protein and interleukins blood levels in postsurgery arginine-enhanced enteral nutrition in head and neck cancer patients. Eur J Clin Nutr. 2003; 57(1): 96–99.
  22. Buijs N, van Bokhorst-de van der Schueren MAE, Langius JAE, et al. Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival. Am J Clin Nutr. 2010; 92(5): 1151–1156.
  23. Jankowski M, Kapała A. Las- Jankowska M. Obecne zalecenia leczenia żywieniowego u chorych na nowotwory złośliwe. Medycyna Praktyczna. : 2016.
  24. Agra IMG, Carvalho AL, Pontes E, et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003; 129(12): 1317–1321.
  25. Kapała A. Analiza wartości odżywczych diety płynnej, szpitalnej. Postępy Żywienia Klinicznego 4(24. 2012; 8: 28–33.
  26. Madhoun MF, Blankenship MM, Blankenship DM, et al. Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol. 2011; 17(8): 1004–1008.
  27. Wiggenraad RGJ, Flierman L, Goossens A, et al. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol. 2007; 32(5): 384–390.
  28. Burney RE, Bryner BS. Safety and long-term outcomes of percutaneous endoscopic gastrostomy in patients with head and neck cancer. Surg Endosc. 2015; 29(12): 3685–3689.
  29. Moleiro J, Faias S, Fidalgo C, et al. Usefulness of Prophylactic Percutaneous Gastrostomy Placement in Patients with Head and Neck Cancer Treated with Chemoradiotherapy. Dysphagia. 2016; 31(1): 84–89.
  30. Nguyen NP, North D, Smith HJ, et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol. 2006; 15(4): 199–203.
  31. http://www.thenacc.co.uk/assets/downloads/170/Food%20Descriptors%20for%20Industry%20Final%20-%20USE.pdf.
  32. Silva Jd, Trindade EB, Fabre ME, et al. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer. 2012; 64(2): 267–273.
  33. Mocellin MC, Camargo CQ, Nunes EA, et al. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin Nutr. 2016; 35(2): 359–369.
  34. Finocchiaro C, Segre O, Fadda M, et al. Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr. 2012; 108(2): 327–333.
  35. Fearon KCH, Von Meyenfeldt MF, Moses AGW, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003; 52(10): 1479–1486.
  36. van der Meij BS, Langius JAE, Spreeuwenberg MD, et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr. 2012; 66(3): 399–404.
  37. Murphy RA, Mourtzakis M, Chu QSC, et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer. 2011; 117(8): 1775–1782.
  38. Trabal J, Leyes P, Forga M, et al. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp. 2010; 25(5): 736–740.
  39. Murphy RA, Mourtzakis M, Chu QSC, et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer. 2011; 117(16): 3774–3780.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl